Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
基本信息
- 批准号:8413001
- 负责人:
- 金额:$ 39.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-16 至 2016-10-31
- 项目状态:已结题
- 来源:
- 关键词:AdenocarcinomaAffectAneuploidyArsenicArsenic TrioxideArsenicalsAttenuatedBiologicalBladderBowen&aposs DiseaseCancer InterventionCarcinogensCell Cycle CheckpointCell Cycle ProgressionCell LineCell divisionCellsChromatidsChromosomal InstabilityChromosomal StabilityChromosome BreakageChromosome SegregationChromosome abnormalityChromosomesChronicColonColon CarcinomaComplementCyclin BCytogeneticsDNADNA DamageDNA RepairDNA biosynthesisDevelopmentDicentric chromosomeDouble MinutesEmbryoEnvironmental CarcinogensEpidemiologic StudiesEpidemiologyEpigenetic ProcessExposure toFibroblastsGemininGenesGeneticGenomic InstabilityGoalsGrowthHCT116 CellsHela CellsHumanHyperplasiaIn VitroKnockout MiceLaboratory ResearchLaboratory StudyLeadLicensing FactorLungMXI1 geneMaintenanceMalignant - descriptorMalignant Childhood NeoplasmMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of urinary bladderMelanoma CellMicrocephalyMicrotubulesMitosisMitoticMolecularMolecular TargetMusMutationNeoplastic Cell TransformationNuclearOncogenicOrganPaclitaxelPlayPopulation StudyProcessPropertyProtein DeregulationProteinsReactive Oxygen SpeciesRegulationReplication LicensingResearchRoleSideSisterSister ChromatidSister Chromatid ExchangeSkinSkin CancerSolid NeoplasmStomachSystemTestingTissuesTubulinanaphase-promoting complexbasecarcinogenesiscarcinogenicitydaughter celldriving forcehuman PTTG1 proteinin vivomicronucleuspolymerizationprematuresegregationskin lesiontumortumor progressiontumorigenesisultraviolet irradiation
项目摘要
DESCRIPTION (provided by applicant): Chronic exposure to arsenic is highly associated with the occurrence of several types of malignancies, including skin, lung and bladder cancer. Despite extensive studies in the past, the mechanism by which arsenic compounds promote carcinogenesis remains largely unclear. Epidemiological studies reveal that arsenic exposure induces the formation of micronuclei, chromosomal aberrations, and aneuploidy, which may be a culprit in the genesis of cancer since most solid tumors are aneuploid. High fidelity DNA replication and faithful distribution of the chromosomal complement to daughter cells during cell division are of paramount importance to the maintenance of chromosomal stability. We previously demonstrated that arsenic trioxide [As(III)] compromises paclitaxel-induced mitotic arrest in both p53-deficient and proficient cells. We have recently shown that As(III) induces chromosomal instability by suppressing the activation of BubR1, a cell cycle checkpoint protein, leading to unscheduled activation of anaphase promoting complex/cyclosome (APC/C) in melanoma and HeLa cells. Activated APC/C apparently causes premature separation of sister chromatids, aberrant sister chromatid exchanges, and diplochromosome formation in cells with wild-type p53. Moreover, mice with haploinsufficiency of BubR1 are prone to the development of skin lesions (hyperplasia) after exposure to UV irradiation. Given the documented effect of As(III) on the induction of nuclear abnormalities, we hypothesize that As(III) compromises the BubR1-dependent spindle checkpoint, resulting in unscheduled activation of APC/C, chromosomal instability, and neoplastic transformation owing to dysregulation of DNA replication and chromosome segregation processes. To test this hypothesis, we will (1) elucidate the molecular basis by which As(III) induces chromosomal instability with an emphasis on studying the Emi1->APC/C->geminin->Cdt1 regulatory axis, (2) determine if As(III) synergizes with spindle checkpoint deficiency in promoting chromosomal instability and oncogenic transformation in vitro, (3) determine if As(III) enhances spontaneous tumor development in BubR1 haploinsufficient mice and investigate if As(III) functions as a co-carcinogen in promoting skin tumorigenesis induced by UV irradiation in these mice. The long term goal of the project is to understand whether the biological properties associated with As(III) are at least partly due to its action on the perturbation of APC/C activities, causing deregulation of proteins crucial for the control of DNA replication and chromosomal segregation during cell division. We anticipate that this line of research will lead to the identification of key molecular targets for cancer intervention, as well as for ameliorating the detrimental effects of arsenic compounds.
描述(由申请人提供):长期暴露于砷与发生多种类型的恶性肿瘤(包括皮肤,肺癌和膀胱癌)高度相关。尽管过去进行了广泛的研究,但砷化合物促进癌变的机制仍然在很大程度上不清楚。流行病学研究表明,砷暴露会诱导微核形成,染色体畸变和非整倍性,这可能是癌症起源的罪魁祸首,因为大多数实体瘤是非整倍性的。在细胞分裂期间,染色体补体对子细胞的高保真DNA复制和忠实分布对于维持染色体稳定性至关重要。我们先前证明了三氧化物[AS(iii)]损害了紫杉醇诱导的p53缺陷和熟练细胞中的有丝分裂停滞。我们最近表明,AS(III)通过抑制BUBR1的激活(一种细胞周期检查点蛋白,从而诱导染色体不稳定性,从而导致黑色素瘤和HELA细胞中促进复合物/循环体(APC/C)的过期激活的激活。活化的APC/C显然会导致姐妹染色单体,异常姐妹染色单体交换和具有野生型p53的细胞中的二氧染色体形成过早分离。此外,暴露于紫外线照射后,具有单倍体不足的BUBR1的小鼠容易发生皮肤病变(增生)。鉴于AS(III)对核异常诱导的效果,我们假设(III)损害了BUBR1依赖性纺锤体检查点,从而导致APC/C,染色体不稳定性的激活,染色体不稳定性,并导致染色体转化,并导致DNA重复的疾病不断变化。 To test this hypothesis, we will (1) elucidate the molecular basis by which As(III) induces chromosomal instability with an emphasis on studying the Emi1->APC/C->geminin->Cdt1 regulatory axis, (2) determine if As(III) synergizes with spindle checkpoint deficiency in promoting chromosomal instability and oncogenic transformation in vitro, (3) determine如果AS(III)增强了BUBR1单倍体肿瘤的自发性肿瘤的发育,并研究AS(III)是否在促进这些小鼠中紫外线辐照引起的皮肤肿瘤发生方面起作用(III)。该项目的长期目标是了解与AS(III)相关的生物学特性至少部分是由于其对APC/C活性扰动的作用,从而导致对控制DNA复制和细胞分裂过程中染色体隔离至关重要的蛋白质。我们预计,这一研究将导致鉴定癌症干预的关键分子靶标,并改善砷化合物的有害作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEI DAI其他文献
WEI DAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEI DAI', 18)}}的其他基金
Chromatin PTEN: Its Regulation And Functions
染色质 PTEN:其调控和功能
- 批准号:
10411363 - 财政年份:2017
- 资助金额:
$ 39.29万 - 项目类别:
Chromatin PTEN: Its Regulation And Functions
染色质 PTEN:其调控和功能
- 批准号:
10200691 - 财政年份:2017
- 资助金额:
$ 39.29万 - 项目类别:
Chromatin PTEN: Its Regulation And Functions
染色质 PTEN:其调控和功能
- 批准号:
10689348 - 财政年份:2017
- 资助金额:
$ 39.29万 - 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
- 批准号:
8250149 - 财政年份:2012
- 资助金额:
$ 39.29万 - 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
- 批准号:
8958809 - 财政年份:2012
- 资助金额:
$ 39.29万 - 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
- 批准号:
8572129 - 财政年份:2012
- 资助金额:
$ 39.29万 - 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新参与者。
- 批准号:
8047101 - 财政年份:2011
- 资助金额:
$ 39.29万 - 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新玩家。
- 批准号:
8794432 - 财政年份:2011
- 资助金额:
$ 39.29万 - 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新参与者。
- 批准号:
8403837 - 财政年份:2011
- 资助金额:
$ 39.29万 - 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新参与者。
- 批准号:
8210839 - 财政年份:2011
- 资助金额:
$ 39.29万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Elucidating the Consequences of Chromosome 3 Arm Aneuploidies in Squamous Cell Carcinoma
阐明鳞状细胞癌中染色体 3 臂非整倍体的后果
- 批准号:
10736206 - 财政年份:2023
- 资助金额:
$ 39.29万 - 项目类别:
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
解构和靶向人类癌症中的非整倍性 - 重新提交 - 1
- 批准号:
10341220 - 财政年份:2021
- 资助金额:
$ 39.29万 - 项目类别:
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
解构和靶向人类癌症中的非整倍性 - 重新提交 - 1
- 批准号:
10610814 - 财政年份:2021
- 资助金额:
$ 39.29万 - 项目类别:
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
解构和靶向人类癌症中的非整倍性 - 重新提交 - 1
- 批准号:
10211797 - 财政年份:2021
- 资助金额:
$ 39.29万 - 项目类别:
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study
使用标志物改善胰腺癌筛查和监测:一项多中心研究
- 批准号:
10701743 - 财政年份:2016
- 资助金额:
$ 39.29万 - 项目类别: